Unexpected inhibitory regulation of glutamate release from rat cerebrocortical nerve terminals by presynaptic 5-hydroxytryptamine-2A receptors

Journal of Neuroscience Research

Volumn 84, Issue 7, 2006, Pages 1528-1542

  Wang, Su Jane ^a   Wang, Kai Yun ^a   Wang, Wei Chieh ^a   Sihra, Talvinder S ^b  

^a FU JEN CATHOLIC UNIVERSITY   (Taiwan)

^b UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

5 hydroxytryptamine; Ca2+ phospholipid dependent protein kinase; Calcium; Glutamate release; Membrane potential; Neurotransmitter; Phospholipase C; Presynaptic G protein coupled receptors; Synaptosomes; Voltage dependent calcium channel

Indexed keywords

1 [2,5 DIMETHOXY 4 IODOPHENYL] 2 AMINOPROPANE; 1 [[6 (3 METHOXYESTRA 1,3,5(10) TRIEN 17BETA YL)AMINO]HEXYL] 1H PYRROLE 2,5 DIONE; 1 [[6 (3 METHOXYESTRA 1,3,5(10) TRIEN 17BETA YL)AMINO]HEXYL] 2,5 PYRROLIDINEDIONE; 2 [1 (3 DIMETHYLAMINOPROPYL) 3 INDOLYL] 3 (3 INDOLYL)MALEIMIDE; 3 [8 [(DIMETHYLAMINO)METHYL] 6,7,8,9 TETRAHYDROPYRIDO[1,2 A]INDOL 10 YL] 4 (1 METHYL 1H INDOL 3 YL) 1H PYRROLE 2,5 DIONE; 4 AMINOPYRIDINE; 8 [4 (5 AMINO 2,4 DIMETHOXYBENZOYL)BUTYL] 1,3,8 TRIAZASPIRO[4.5]DECANE 2,4 DIONE; CALCIUM; CALCIUM CHANNEL; GLUTAMIC ACID; IONOMYCIN; KETANSERIN; PHOSPHOLIPASE C; PHOSPHOLIPASE C INHIBITOR; POTASSIUM CHLORIDE; PRESYNAPTIC RECEPTOR; PROTEIN KINASE C; SEROTONIN 2A AGONIST; SEROTONIN 2A RECEPTOR; SEROTONIN 2C AGONIST; SEROTONIN 2C RECEPTOR; SUCROSE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ARTICLE; BRAIN CORTEX; CONTROLLED STUDY; DRUG EFFECT; DRUG MECHANISM; MALE; NERVE CONDUCTION; NERVE ENDING; NERVE EXCITABILITY; NONHUMAN; PRIORITY JOURNAL; RAT; SIGNAL TRANSDUCTION; SYNAPTOSOME;

AMPHETAMINES; ANIMALS; CALCIUM; CALCIUM CHANNEL BLOCKERS; CEREBRAL CORTEX; DICARBOXYLIC ACIDS; DRUG INTERACTIONS; ENZYME INHIBITORS; GLUTAMIC ACID; KETANSERIN; MALE; MEMBRANE POTENTIALS; NEURAL INHIBITION; NEUROTRANSMITTER UPTAKE INHIBITORS; OMEGA-AGATOXIN IVA; OMEGA-CONOTOXIN GVIA; PRESYNAPTIC TERMINALS; PYRROLIDINES; RATS; RATS, SPRAGUE-DAWLEY; RECEPTOR, SEROTONIN, 5-HT2A; SEROTONIN AGONISTS; SEROTONIN ANTAGONISTS; SPIRO COMPOUNDS; SULFONAMIDES; SYNAPTOSOMES; TIME FACTORS;

EID: 33750599344     PISSN: 03604012     EISSN: 10974547     Source Type: Journal    
DOI: 10.1002/jnr.21060     Document Type: Article

References (72)

1. Aghajanian GK, Marek GJ. 1997. Serotonin induces excitatory postsynaptic potentials in apical dendrites of neocortical pyramidal cells. Neuropharmacology 36:589-599.
2. Aghajanian GK, Marek GJ. 1999a. Serotonin and hallucinogens. Neuropsychopharmacology 21:165-235.
3. 2A receptors, increases EPSCs in layer V pyramidal cells of prefrontal cortex by an asynchronous mode of glutamate release. Brain Res 825:161-171.
4. Aghajanian GK, Marek GJ. 2000. Serotonin model of schizophrenia: emerging role of glutamate mechanisms. Brain Res Brain Res Rev 31:302-312.
5. Barnes NM, Sharp T. 1999. A review of central 5-HT receptors and their function. Neuropharmacology 38:1083-1152.
6. Barrie AP, Nicholls DG, Sanchez-Prieto J, Sihra TS. 1991. An ion channel locus for the protein kinase C potentiation of transmitter glutamate release from guinea pig cerebrocortical synaptosomes. J Neurochem 57:1398-1404.
7. 2A receptor-mediated outward current in C6 glioma cells is mimicked by intracellular IP3 release. Neuroreport 5:1245-1248.
8. Baxter G, Kennett G, Blaney F, Blackburn T. 1995. 5-HT2 receptor subtypes: a family re-united? Trends Pharmacol Sci 16:105-110.
9. Beal MF. 1992. Mechanisms of excitotoxicity in neurologic diseases. FASEB J 6:3338-3344.
10. Bennett-Clarke CA, Chiaia NL, Crissman RS, Rhoades RW. 1991. The source of the transient serotoninergic input to the developing visual and somatosensory cortices in rat. Neuroscience 43:163-183.
11. 2+ entry. Science 292:293-297.
12. Blackmer T, Larsen EC, Bartleson C, Kowalchyk JA, Yoon EJ, Preininger AM, Alford S, Hamm HE, Martin TF. 2005. G protein betagamma directly regulates SNARE protein fusion machinery for secretory granule exocytosis. Nat Neurosci 8:421-425.
13. Bradford MM. 1976. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 72:248-254.
14. Buhot MC. 1997. Serotonin receptors in cognitive behaviors. Curr Opin Neurobiol 7:243-254.
15. Buhot MC, Martin S, Segu L. 2000. Role of serotonin in memory impairment. Ann Med 32:210-221.
16. Chen A, Hough CJ, Li H. 2003. Serotonin type II receptor activation facilitates synaptic plasticity via N-methyl-D-aspartate-mediated mechanism in the rat basolateral amygdala. Neuroscience 119:53-63.
17. Coffey ET, Sihra TS, Nicholls DG. 1993. Protein kinase C and the regulation of glutamate exocytosis from cerebrocortical synaptosomes. J Biol Chem 268:21060-21065.
18. Coffey ET, Herrero I, Sihra TS, Sanchez Prieto J, Nicholls DG. 1994. Glutamate exocytosis and MARCKS phosphorylation are enhanced by a metabotropic glutamate receptor coupled to a protein kinase C synergistically activated by diacylglycerol and arachidonic acid [published erratum appears in J Neurochem 64:471). J Neurochem 63:1303-1310.
19. Danysz W, Parsons AC. 1998. Glycine and N-methyl-D-aspartate receptors: physiological significance and possible therapeutic applications. Pharmacol Rev 50:597-664.
20. Dunkley PR, Jarvie PE, Heath JW, Kidd GJ, Rostas JA. 1986. A rapid method for isolation of synaptosomes on Percoll gradients. Brain Res 372:115-129.
21. Duxon MS, Flanigan TP, Reavley AC, Baxter GS, Blackburn TP, Fone KC. 1997. Evidence for expression of the 5-hydroxytryptamine-2B receptor protein in the rat central nervous system. Neuroscience 76:323-329.
22. Edagawa Y, Saito H, Abe K. 2000. The serotonin 5-HT2 receptor- phospholipase C system inhibits the induction of long-term potentiation in the rat visual cortex. Eur J Neurosci 12:1391-1396.
23. + and glutamate receptor agonists on the membrane potential of suspensions of primary cultures of rat astrocytes as measured with a cyanine dye, DiS-C2-(5). Brain Res 462:67-75.
24. Garro MA, Lopez dJ, Ruiz dAI, Callado LF, Meana JJ, Salles J. 2001. Regulation of phospholipase Cbeta activity by muscarinic acetylcholine and 5-HT(2) receptors in crude and synaptosomal membranes from human cerebral cortex. Neuropharmacology 40:686-695.
25. 2+ indicators with greatly improved fluorescence properties. J Biol Chem 260:3440-3450.
26. Herrero I, Miras-Portugal MT, Sanchez-Prieto J. 1998. Functional switch from facilitation to inhibition in the control of glutamate release by metabotropic glutamate receptors. J Biol Chem 273:1951-1958.
27. Hoyer D, Martin G. 1997. 5-HT receptor classification and nomenclature: towards a harmonization with the human genome. Neuropharmacology 36:419-428.
28. Hoyer D, Clarke DE, Fozard JR, Hartig PR, Martin GR, Mylecharane EJ, Saxena PR, Humphrey PP. 1994. International Union of Pharmacology classification of receptors for 5-hydroxytryptamine (serotonin). Pharmacol Rev 46:157-203.
29. Jakab RL, Goldman-Rakic PS. 1998. 5-Hydroxytryptamine2A serotonin receptors in the primate cerebral cortex: possible site of action of hallucinogenic and antipsychotic drugs in pyramidal cell apical dendrites. Proc Natl Acad Sci U S A 95:735-740.
30. 2C receptors. Neuropsychopharmacology 18:339-351.
31. Lambe EK, Aghajanian GK. 2001. The role of Kv1.2-containing potassium channels in serotonin-induced glutamate release from thalamocortical terminals in rat frontal cortex. J Neurosci 21:9955-9963.
32. Li M, West JW, Numann R, Murphy BJ, Scheuer T, Catterall WA. 1993. Convergent regulation of sodium channels by protein kinase C and cAMP-dependent protein kinase. Science 261:1439-1442.
33. Marcoli M, Rosu C, Bonfanti A, Raiteri M, Maura G. 2001. Inhibitory presynaptic 5-hydroxytryptamine(2A) receptors regulate evoked glutamate release from rat cerebellar mossy fibers. J Pharmacol Exp Ther 299:1106-1111.
34. 2A receptor antagonist. Eur J Pharmacol 259:137-141.
35. 2A receptor or alpha 1-adrenoceptor activation induces excitatory postsynaptic currents in layer V pyramidal cells of the medial prefrontal cortex. Eur J Pharmacol 367:197-206.
36. Marek GJ, Wright RA, Schoepp DD, Monn JA, Aghajanian GK. 2000. Physiological antagonism between 5-hydroxytryptamine(2A) and group II metabotropic glutamate receptors in prefrontal cortex. J Pharmacol Exp Ther 292:76-87.
37. Maura G, Carbone R, Guido M, Pestarino M, Raiteri M. 1991. 5-HT2 presynaptic receptors mediate inhibition of glutamate release from cerebellar mossy fibre terminals. Eur J Pharmacol 202:185-190.
38. Mengod G, Pompeiano M, Martinez-Mir MI, Palacios JM. 1990. Localization of the mRNA for the 5-HT2 receptor by in situ hybridization histochemistry. Correlation with the distribution of receptor sites. Brain Res 524:139-143.
39. Miner LA, Backstrom JR, Sanders-Bush E, Sesack SR. 2003. Ultrastructural localization of serotonin2A receptors in the middle layers of the rat prelimbic prefrontal cortex. Neuroscience 116:107-117.
40. Naughton M, Mulrooney JB, Leonard BE. 2000. A review of the role of serotonin receptors in psychiatric disorders. Hum Psychopharmacol 15:397-415.
41. Nicholls DG. 1989. Release of glutamate, aspartate, and gamma-amino-butyric acid from isolated nerve terminals. J Neurochem 52:331-341.
42. Nicholls DG. 1993. The glutamatergic nerve terminal. Eur J Biochem 212:613-631.
43. Nicholls DG. 1998. Presynaptic modulation of glutamate release. Prog Brain Res 116:15-22.
44. Nicholls DG, Sihra TS. 1986. Synaptosomes possess an exocytotic pool of glutamate. Nature 321:772-773.
45. Nicholls DG, Sihra TS, Sanchez-Prieto J. 1987. The role of the plasma membrane and intracellular organelles in synaptosomal calcium regulation [review]. Soc Gen Physiol Ser 42:31-43.
46. Nicoll RA. 1988. The coupling of neurotransmitter receptors to ion channels in the brain. Science 241:545-551.
47. Oleskevich S, Descarries L. 1990. Quantified distribution of the serotonin innervation in adult rat hippocampus. Neuroscience 34:19-33.
48. Perkinton MS, Sihra TS. 1998. Presynaptic GABA(B) receptor modulation of glutamate exocytosis from rat cerebrocortical nerve terminals: receptor decoupling by protein kinase C. J Neurochem 70:1513-1522.
49. + channel beta subunits. Ann N Y Acad Sci 868:344-355.
50. + channels of the mammalian brain. FASEB J 5:164-170.
51. Rodriguez-Moreno A, Sistiaga A, Lerma J, Sanchez-Prieto J. 1998. Switch from facilitation to inhibition of excitatory synaptic transmission by group I mGluR desensitization. Neuron 21:1477-1486.
52. Rosenmund C, Stevens CF. 1996. Definition of the readily releasable pool of vesicles at hippocampal synapses. Neuron 16:1197-1207.
53. Sanchez-Prieto J, Budd DC, Herrero I, Vazquez E, Nicholls DG. 1996. Presynaptic receptors and the control of glutamate exocytosis. Trends Neurosci 19:235-239.
54. Santana N, Bortolozzi A, Serrats J, Mengod G, Artigas F. 2004. Expression of serotonin IA and serotonin2A receptors in pyramidal and GABAergic neurons of the rat prefrontal cortex. Cereb Cortex 14:1100-1109.
55. Scruggs JL, Schmidt D, Deutch AY. 2003. The hallucinogen 1-[2,5-dimethoxy-4-iodophenyl]-2-arninopropane (DOI) increases cortical extracellular glutamate levels in rats. Neurosci Lett 346:137-140.
56. Sihra TS. 1997. Protein phosphorylation and dephosphorylation in isolated nerve terminals (synaptosomes). In Hemmings HC, editor. Posttranslational modifications: techniques and protocols. Totowa, NJ: Humana Press, p 67-119.
57. Sihra TS, Nichols RA. 1993. Mechanisms in the regulation of neurotransmitter release from brain nerve terminals: current hypotheses [review]. Neurochem Res 18:47-58.
58. 2+ entry preferentially effects protein dephosphorylation, phosphorylation, and glutamate release. J Biol Chem 267:1983-1989.
59. Sistiaga A, Sanchez-Prieto J. 2000. Protein phosphatase 1 and 2A inhibitors prolong the switch in the control of glutamate release by group I metabotropic glutamate receptors: characterization of the inhibitory pathway. J Neurochem 75:1566-1574.
60. Skolnick P, Layer RT, Popik P, Nowak G, Paul IA, Trullas R. 1996. Adaptation of N-methyl-D-aspartate (NMDA) receptors following antidepressant treatment: implications for the pharmacotherapy of depression. Pharmacopsychiatry 29:23-26.
61. 2C receptors. Pharmacol Biochem Behav 61:323-330.
62. Szatkowski M, Attwell D. 1994. Triggering and execution of neuronal death in brain ischaemia: two phases of glutamate release by different mechanisms. Trends Neurosci 17:359-365.
63. Tanaka E, North RA. 1993. Actions of 5-hydroxytryptamine on neurons of the rat cingulate cortex. J Neurophysiol 69:1749-1757.
64. 2+ and glutamate release. J Neurochem 53:1693-1699.
65. Vazquez E, Sanchez-Prieto J. 1997. Presynaptic modulation of glutamate release targets different calcium channels in rat cerebrocortical nerve terminals. Eur J Neurosci 9:2009-2018.
66. Wang SJ. 2005. Potential antidepressant LY 367265 presynaptically inhibits the release of glutamate in rat cerebral cortex. Synapse 55:156-163.
67. Wang SJ, Sihra TS. 2003. Opposing facilitatory and inhibitory modulation of glutamate release elicited by cAMP production in cerebrocortical nerve terminals (synaptosomes). Neuropharmacology 44:686-697.
68. 2+ entry in rat cerebrocortical nerve terminals (synaptosomes). J Pharmacol Exp Ther 309:951-958.
69. Wang SJ, Coutinho V, Sihra TS. 2002. Presynaptic cross-talk of beta-adrenoreceptor and 5-hydroxytryptamine receptor signalling in the modulation of glutamate release from cerebrocortical nerve terminals. Br J Pharmacol 137:1371-1379.
70. Wiley JL, Cristello AF, Balster RL. 1995. Effects of site-selective NMDA receptor antagonists in an elevated plus-maze model of anxiety in mice. Eur J Pharmacol 294:101-107.
71. 2A receptors are expressed on pyramidal cells and interneurons in the rat cortex. Synapse 27:79-82.
72. Zhou FM, Hablitz JJ. 1999. Activation of serotonin receptors modulates synaptic transmission in rat cerebral cortex. J Neurophysiol 82:2989-2999.